These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28407694)

  • 21. Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
    Ishiura Y; Ishimaru H; Watanabe T; Fujimuro M
    Biol Pharm Bull; 2019; 42(12):2109-2112. PubMed ID: 31787726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.
    Haddad L; El Hajj H; Abou-Merhi R; Kfoury Y; Mahieux R; El-Sabban M; Bazarbachi A
    Leukemia; 2008 Apr; 22(4):826-34. PubMed ID: 18094712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.
    Bi X; Yang L; Mancl ME; Barnes BJ
    J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma.
    Ahuja A; Journo G; Eitan R; Rubin E; Shamay M
    Oncogene; 2021 Jan; 40(3):536-550. PubMed ID: 33188297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy.
    Sakamoto T; Ajiro M; Watanabe A; Matsushima S; Ueda K; Hagiwara M
    BMC Cancer; 2023 Jan; 23(1):71. PubMed ID: 36670405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human herpesvirus 8 interleukin-6 contributes to primary effusion lymphoma cell viability via suppression of proapoptotic cathepsin D, a cointeraction partner of vitamin K epoxide reductase complex subunit 1 variant 2.
    Chen D; Gao Y; Nicholas J
    J Virol; 2014 Jan; 88(2):1025-38. PubMed ID: 24198402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.
    Yang D; Chen W; Xiong J; Sherrod CJ; Henry DH; Dittmer DP
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4762-8. PubMed ID: 25341731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma.
    Goto H; Kariya R; Kudo E; Katano H; Okada S
    Neoplasia; 2024 Oct; 56():101035. PubMed ID: 39096792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
    Caro-Vegas C; Bailey A; Bigi R; Damania B; Dittmer DP
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
    Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
    Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
    Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
    Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma.
    Manzano M; Patil A; Waldrop A; Dave SS; Behdad A; Gottwein E
    Nat Commun; 2018 Aug; 9(1):3263. PubMed ID: 30111820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases.
    Pan ZG; Zhang QY; Lu ZB; Quinto T; Rozenvald IB; Liu LT; Wilson D; Reddy V; Huang Q; Wang HY; Ren YS
    Am J Surg Pathol; 2012 Aug; 36(8):1129-40. PubMed ID: 22790853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
    Ueno M; Kariya R; Sittithumcharee G; Okada S
    Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.
    Roy D; Dittmer DP
    Am J Pathol; 2011 Oct; 179(4):2108-19. PubMed ID: 21819957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nigericin Induces Apoptosis in Primary Effusion Lymphoma Cells by Mitochondrial Membrane Hyperpolarization and β-Catenin Destabilization.
    Umeyama H; Shigemi Z; Baba Y; Hara N; Watanabe T; Fujimuro M
    Anticancer Res; 2023 Jun; 43(6):2455-2465. PubMed ID: 37247906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells.
    He M; Tan B; Vasan K; Yuan H; Cheng F; Ramos da Silva S; Lu C; Gao SJ
    J Pathol; 2017 Jul; 242(3):309-321. PubMed ID: 28393364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KSHV-infected PEL cell lines exhibit a distinct gene expression profile.
    Ueda K; Ito E; Karayama M; Ohsaki E; Nakano K; Watanabe S
    Biochem Biophys Res Commun; 2010 Apr; 394(3):482-7. PubMed ID: 20175997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
    Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
    J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.